ARMISTICE CAPITAL, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for ARMISTICE CAPITAL, LLC with $3.2B in long positions as of Q3 2025, 61% allocated to Healthcare, and 34% concentrated in top 10 positions.

Portfolio Value: $3.2B
Top 10 Concentration: 34%
Top Sector: Healthcare (61%)
US Exposure: 98%
Market Cap Focus: Mid Cap
Countries: 15

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare

60.50%

Technology

12.50%

Consumer Cyclical

10.10%

Consumer Defensive

3.60%

Communication Services

2.50%

Financial Services

0.50%

Industrials

0.30%

Basic Materials

0.30%

Energy

0.20%

Real Estate

0.10%

Utilities

0.10%

Industry Breakdown

87 industries across all sectors

Biotechnology

Healthcare

35.38%

Drug Manufacturers - Specialty & Generic

Healthcare

8.08%

Medical - Devices

Healthcare

6.06%

Software - Infrastructure

Technology

5.71%

Software - Application

Technology

4.65%

Specialty Retail

Consumer Cyclical

3.73%

Medical - Instruments & Supplies

Healthcare

3.53%

Medical - Diagnostics & Research

Healthcare

3.07%

Packaged Foods

Consumer Defensive

2.58%

Internet Content & Information

Communication Services

2.32%

Gambling, Resorts & Casinos

Consumer Cyclical

2.06%

Medical - Healthcare Information Services

Healthcare

1.90%

Market Cap Distribution

Mega Cap (> $200B)

7.11%

Large Cap ($10B - $200B)

31.64%

Mid Cap ($2B - $10B)

34.64%

Small Cap ($300M - $2B)

13.66%

Micro Cap ($50M - $300M)

3.28%

Nano Cap (< $50M)

1.62%

N/A (ETF or Unknown)

8.05%

Portfolio Concentration

Top 10 Holdings %

33.88%

Top 20 Holdings %

50.17%

Top 50 Holdings %

75.34%

Top 100 Holdings %

93.16%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)

97.57%

International

2.43%

Countries

Largest Int'l Market

Ireland - 1.37%

United States of America

97.57% ($3.1B)

285 holdings

Ireland

1.37% ($43.3M)

3 holdings

Taiwan

0.50% ($15.8M)

1 holdings

Finland

0.18% ($5.8M)

1 holdings

Canada

0.08% ($2.5M)

4 holdings

Bermuda

0.05% ($1.7M)

3 holdings

Luxembourg

0.05% ($1.6M)

1 holdings

United Kingdom

0.04% ($1.2M)

3 holdings

Israel

0.04% ($1.2M)

3 holdings

Switzerland

0.04% ($1.1M)

3 holdings

Germany

0.03% ($930.5K)

2 holdings

Uruguay

0.02% ($574.9K)

1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10: 19.1 quarters
Avg. Top 20: 15.8 quarters
Avg. All Positions: 3.3 quarters
Median Holding Period: 0 quarters
Persistence Rate: 26.84%
Persistent Holdings Weight: 74.47%
Persistent Positions: 84
Longest Held: Madrigal Pharmaceuticals, Inc. Common StockMDGL - 37 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position: 0.04%
Avg. Position Weight: 0.32%
Largest Position: PTC Therapeutics, Inc.PTCT - 6.38%
Largest Ownership Stake: Dermata Therapeutics, Inc. Common StockDRMA - 11.98%
Avg. Ownership Stake: 2.06%
Ownership Stake >5%: 22
Ownership Stake >1%: 51

Historical (Since Q4 2014)

Avg. New Position: 0.76%
Avg. Ownership Stake: 32.36%
Largest Position: Avalo Therapeutics, Inc. Common StockAVTX - 98.27% (Q4 2021)
Largest Ownership Stake: BRAINSTORM CELL THERAPUTCBCLI - 100.00% (Q3 2024)

Portfolio Turnover

Current Quarter

Turnover Ratio: 27.0%
Value Traded: $850.68M
Positions Added: 124
Positions Exited: 63

Historical (Since Q4 2014)

Avg. Turnover Ratio: 47.3%
Avg. Positions Added: 31
Avg. Positions Exited: 38
Highest Turnover: 505.7%
Q3 2022
Lowest Turnover: 0.5%
Q4 2021

ARMISTICE CAPITAL, LLC Portfolio Analytics

Composition Analysis

Sector Allocation

Industry Breakdown

Filter by Sector

Market Cap Distribution

Portfolio Concentration

Geographic Exposure

Holding Behavior

Portfolio Stability & Commitment

Position Sizing & Influence

Current Quarter

Historical (Since Q4 2014)

Portfolio Turnover

Current Quarter

Historical (Since Q4 2014)

Cookie Preferences